Cytophenix
PrivateLast Round
Pre Seed
Oct 28, 2025
Total Funding Raised
$1.54M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cytophenix is a biotechnology company developing a medical diagnostic platform for rapid antimicrobial susceptibility testing to help clinicians make timely and informed antibiotic treatment decisions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytophenix Comparables
Compare Cytophenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FASTinov | 87% | |
| Gradientech | 87% | |
| Vivid Dx | 86% |
Cytophenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 28, 2025 | ||||
| Grant | Sep 11, 2024 | ||||
| Accelerator | Jun 5, 2024 | ||||
| Grant | May 24, 2023 |
Cytophenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CUREator | Grant |
| Brandon Capital | Grant |
| CSIRO ON Accelerate | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Grew 43% QoQ from 7 to 10 employees.
- Oct 28, 2025
$860K raised in Pre Seed round.
Cytophenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cytophenix's valuation, stock price, and market status.
Is Cytophenix a public or private company?
Cytophenix is a private company.
What is the current stock price of Cytophenix?
Cytophenix is a private company with no public stock price. No recent secondary market data is available.
How much is Cytophenix worth (valuation)?
Valuation information for Cytophenix is not publicly available.
Can I buy Cytophenix stock?
Cytophenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cytophenix's last funding round?
Cytophenix's most recent funding round was Pre Seed on October 28, 2025.
Who are the main investors in Cytophenix?
Key investors in Cytophenix include CUREator, Brandon Capital, CSIRO ON Accelerate.
Will Cytophenix IPO soon?
No public IPO plans have been announced for Cytophenix.
How can I track Cytophenix secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cytophenix's secondary market activity and sign up for updates.